Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a potent inhibitor that blocks dopamine uptake (IC50 : 1-51 nM)
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 32.00 | |
10 mg | In stock | $ 52.00 | |
25 mg | In stock | $ 94.00 | |
50 mg | In stock | $ 138.00 | |
100 mg | In stock | $ 198.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 54.00 |
Description | Vanoxerine dihydrochloride (GBR-12909 dihydrochloride) is a potent inhibitor that blocks dopamine uptake (IC50 : 1-51 nM) |
Targets&IC50 | Dopamine uptake:1-51 nM |
In vivo | In 9 SP dogs, 11 episodes each of sustained (>10 minutes) AF and AFL were induced. Electrophysiological studies were performed before and after infusion of vanoxerine, which effectively terminated AF and AFL in 19 of 22 episodes. Simultaneous multisite mapping during 3 AF and 3 AFL episodes demonstrated that termination of each arrhythmia occurred with termination of the driver (a reentrant circuit) following an increase in tachycardia CL. Except for conduction in an area of slow conduction in the driver's reentrant circuit, vanoxerine did not significantly affect intraatrial or atrioventricular conduction time, QRS duration, or QT/QTc intervals. Ventricular refractoriness prolonged minimally during ventricular pacing at 400 and 333 ms (176 +/- 16 ms to 182 +/- 16 ms; 173 +/- 11 ms to 178 +/- 18 ms, respectively). Vanoxerine minimally increased (mean 0.7 mA) atrial stimulus threshold for capture[1].Vanoxerine dihydrochloridealso blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM)[2]. |
Synonyms | GBR-12909 dihydrochloride, I893 dihydrochloride |
Molecular Weight | 523.49 |
Formula | C28H34Cl2F2N2O |
CAS No. | 67469-78-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9.4 mg/mL (17.96 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Vanoxerine dihydrochloride 67469-78-7 GPCR/G Protein Neuroscience Dopamine Receptor GBR-12909 GBR-12909 dihydrochloride I 893 Inhibitor SLC6A3 Vanoxerine GBR12909 inhibit I-893 DAT I893 Dihydrochloride GBR 12909 Dihydrochloride I 893 Dihydrochloride I-893 Dihydrochloride GBR12909 Dihydrochloride Dopamine Transporter I893 dihydrochloride GBR 12909 I893 GBR-12909 Dihydrochloride Vanoxerine Dihydrochloride inhibitor